IVE | PRF | IVE / PRF | |
Gain YTD | 3.841 | 6.251 | 61% |
Net Assets | 39.4B | 7.76B | 508% |
Total Expense Ratio | 0.18 | 0.33 | 55% |
Turnover | 32.00 | 6.00 | 533% |
Yield | 1.91 | 1.76 | 109% |
Fund Existence | 25 years | 20 years | - |
IVE | PRF | |
---|---|---|
RSI ODDS (%) | 2 days ago76% | 2 days ago76% |
Stochastic ODDS (%) | 2 days ago76% | 2 days ago90% |
Momentum ODDS (%) | 2 days ago63% | 2 days ago67% |
MACD ODDS (%) | 2 days ago74% | 2 days ago75% |
TrendWeek ODDS (%) | 2 days ago73% | 2 days ago74% |
TrendMonth ODDS (%) | 2 days ago76% | 2 days ago76% |
Advances ODDS (%) | 15 days ago83% | 15 days ago84% |
Declines ODDS (%) | 6 days ago75% | 6 days ago74% |
BollingerBands ODDS (%) | 2 days ago88% | 2 days ago90% |
Aroon ODDS (%) | 2 days ago78% | 2 days ago79% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XSW | 185.37 | 1.97 | +1.08% |
SPDR® S&P Software & Services ETF | |||
EMLC | 25.14 | 0.10 | +0.40% |
VanEck JPMorgan EMLcl Ccy Bd ETF | |||
BCLO | 49.76 | 0.02 | +0.05% |
iShares BBB-B CLO Active ETF | |||
LSAF | 42.33 | -0.02 | -0.05% |
LeaderSharesTM AlphaFactor® US Cr Eq ETF | |||
BBP | 62.96 | -0.37 | -0.59% |
Virtus LifeSci Biotech Products ETF |
A.I.dvisor indicates that over the last year, PRF has been closely correlated with BAC. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRF jumps, then BAC could also see price increases.